title: Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
abstract: We report on 7 patients with severe, complicated Kawasaki disease treated with oral prednisolone, after apparently unsuccessful intravenous immunoglobulin treatment. An additional eighth patient was a Jehovah's Witness, who was given steroid and aspirin as first-line treatment. These findings support a beneficial role for steroids in intravenous immunoglobulin-resistant Kawasaki disease.
authors.affiliation: Great Ormond Street Hospital for Children, London, England.
authors.forename: R C
authors.initials: RC
authors.lastname: Dale
authors.forename: M A
authors.initials: MA
authors.lastname: Saleem
authors.forename: S
authors.initials: S
authors.lastname: Daw
authors.forename: M J
authors.initials: MJ
authors.lastname: Dillon
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use*; D017211:Treatment Failure
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D010975:Platelet Aggregation Inhibitors; D011239:Prednisolone; D001241:Aspirin